Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by Croupier2on Jan 24, 2014 9:50am
251 Views
Post# 22129321

RE:RE:RE:RE:RE:RE:RE:RE:RE:Insider Buying !

RE:RE:RE:RE:RE:RE:RE:RE:RE:Insider Buying !David sold another 100 K

Last: 0.55   Change: -0.02    Volume: 21,500   Last Trade: 09:43  

  Level ll Quote
  Bid     Ask
  Price   Total Size   # of Orders     Price   Total Size   # of Orders
$0.55 2 1   $0.57 111 5
$0.53 3 1   $0.58 52 1
$0.52 16 2   $0.59 100 3
$0.51 24 3   $0.60 50 1
$0.50 20 1   $0.61 21 1
$0.49 20 1   $0.62 1 1
$0.485 40 1   $0.63 28 2
$0.48 20 2   $0.64 134 3
$0.47 20 1   $0.65 130 3
$0.465 13 1   $0.66 5 1
 

Bullboard Posts